Gastrointestinal perforation related to lenvatinib, an anti-angiogenic inhibitor that targets multiple receptor tyrosine kinases, in a patient with metastatic thyroid cancer
Crossref DOI link: https://doi.org/10.1007/s10637-017-0522-4
Published Online: 2017-10-11
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Date, Emi
Okamoto, Kunio
Fumita, Souichi
Kaneda, Hiroyasu http://orcid.org/0000-0002-7696-2391
Text and Data Mining valid from 2017-10-11
Version of Record valid from 2017-10-11
Article History
Received: 13 September 2017
Accepted: 5 October 2017
First Online: 11 October 2017
Compliance with ethical standards
:
: The authors declare no potential conflicts of interest.